The first regulatory submission for a CRISPR-based therapy has been validated by the European Medicines Agency, to treat sickle cell disease and transfusion-dependent beta thalassemia.
Watch How Humans Solve Problems
Humans are on an eternal quest to solve problems, whether you realise it or not (but as a scientist, you probably do!).